Study of a 532/1064 Fractional Picosecond Laser for Facial Rejuvenation

Dermatol Surg. 2022 Jan 1;48(1):109-113. doi: 10.1097/DSS.0000000000003229.

Abstract

Background and objectives: Picosecond (ps) fractional lasers create small wounds, presumably by laser-induced optical breakdown. We studied a ps fractional laser in the treatment of wrinkles and mottled pigment.

Materials and methods: This was a single center, prospective, open-label clinical trial. Patients with at least 2 facial areas, with visible wrinkles and dyschromia, were enrolled in the study and received 3 treatments at monthly intervals and appeared at 3 follow-up visits at 1, 3, and 6 months after treatment. The laser is an 800 ps fractional system with nominal 10 mm macrospot diameter. Both 532 nm and 1,064 nm wavelengths were applied in each subject. Wrinkle and pigmentation clearance were assessed by 2 blinded investigators using a 5-point clearance scale. Skin improvement was assessed by investigators using the 5-point Global Aesthetic Improvement (GAI) Scale based on before/after photographs for the following categories: (1) fine lines/wrinkles and (2) pigmentation.

Results: A total of 18 healthy subjects at a single site were enrolled. At least moderate pigmentation and fine line/wrinkles improvement were observed in 93% and 79% of patients at 1 month after the last treatment according to GAI, respectively. Pigment clearance approached a mean of approximately 40%.

Conclusion: A ps 1,064/532 fractional laser achieves reduction in fine lines and pigment.

Publication types

  • Clinical Trial

MeSH terms

  • Esthetics
  • Face
  • Female
  • Follow-Up Studies
  • Healthy Volunteers
  • Humans
  • Laser Therapy / instrumentation
  • Laser Therapy / methods*
  • Middle Aged
  • Prospective Studies
  • Rejuvenation
  • Skin Aging / radiation effects*
  • Skin Pigmentation / radiation effects*
  • Treatment Outcome